Tiamson, Cris Reyden B.

HRN: 22-48-67  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2023
CEFUROXIME 750MG (VIAL)
05/08/2023
05/14/2023
IV
325mg
Q8h
URTI
Waiting Final Action 
05/09/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
05/09/2023
05/13/2023
PO
2.5ml
OD
Bronchial Asthma In Acute Exacerbation; URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: